XML 37 R14.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Warrants And Options | 12 Months Ended
--- | ---
Dec. 31, 2015
Notes to Financial Statements |
Note 8 - Warrants And Options | a) Warrants 2015 On February 23, 2015, 25,000 warrants were exercised at a price of $2.20 per share, for net cash proceeds of $55,000. As a result, a total of 25,000 shares of common stock were issued. On May 10, 2015, 26,685 warrants with an exercise price of $1.75 per share terminated by their terms. On June 11, 2015, 100,000 warrants were exercised at a price of $0.50 per share, for net cash proceeds of $50,000. As a result, a total of 100,000 shares of common stock were issued. On July 20, 2015, 25,000 warrants were exercised at a price of $2.20 per share, for net cash proceeds of $55,000. As a result, a total of 25,000 shares of common stock were issued. On September 16, 2015, 12,500 warrants were exercised at a price of $2.20 per share, for net cash proceeds of $27,500. As a result, a total of 12,500 shares of common stock were issued. On October 6, 2015, 100,000 warrants were exercised at a price of $2.20 per share, for net cash proceeds of $220,000. As a result, a total of 100,000 shares of common stock were issued. On October 28, 2015, 300,000 warrants were exercised at a price of $2.20 per share, for net cash proceeds of $660,000. As a result, a total of 300,000 shares of common stock were issued. On December 1, 2015, 8,000 warrants were exercised at a price of $2.40 per share, for net cash proceeds of $19,200. As a result, a total of 8,000 shares of common stock were issued. On December 14, 2015, a related party exercised 250,000 warrants at a price of $1.05 per share, for net cash proceeds of $262,500. As a result, a total of 250,000 shares of common stock were issued. 2014 On January 28, 2014, the Company issued 10,000 warrants to a consultant for services at an exercise price of $2.40, exercisable immediately for three years. The warrants were valued at $21,500 using the Black-Scholes Option Pricing model using the following assumptions: Three-year term, $2.26 stock price, $2.40 exercise price, 229% volatility, 0.75% risk free rate. On February 26, 2014, the Company issued 1,500,000 warrants attached to the issue of 1,500,000 shares for cash totaling $3,000,000. The Company has valued these warrants at $3,995,547 and treated this amount as a derivative liability, in accordance with ASC 815. The warrants are exercisable immediately for five years at an exercise price of $2.20. On February 26, 2014, the Company issued 30,975 warrants to agents as part remuneration in respect of the issuance of 1,500,000 shares for cash totaling $3,000,000. The warrants were valued at $82,507 using the Black-Scholes Option Pricing model using the following assumptions: Five-year term, $2.68 stock price, $2.20 exercise price, 241% volatility, 1.5% risk free rate. The Company has treated this amount as a derivative liability, in accordance with ASC 815. Each warrant is exercisable immediately for five years at an exercise price of $2.20 per share. On September 5, 2014, the Company issued 10,000 warrants to a consultant for services. These warrants were valued at $20,092 using the Black-Scholes Option Pricing model using the following assumptions: Three year term, $2.10 stock price, $2.40 exercise price, 236% volatility, 0.99% risk free rate. Each warrant is exercisable immediately for three years at an exercise price of $2.40 per share. On September 26, 2014, the Company issued 24,000 warrants to an agent as part remuneration in respect of the issuance of 300,000 shares for net proceeds of $688,970. These warrants were valued at $103,223 using the Black-Scholes Option Pricing model using the following assumptions: Three year term, $4.45 stock price, $3 exercise price, 235% volatility, 1.08% risk free rate. Each warrant is exercisable immediately for three years at an exercise price of $3 per share. On October 1, 2014, 25,000 of the remaining 175,000 warrants with variable vesting dates, issued March 20, 2013, vested. The 25,000 warrants were valued at $104,281 using the Black-Scholes Option Pricing model using the following assumptions: Three-year term, $4.21 stock price, $2.47 exercise price, 235% volatility, 1.0 % risk free rate. The Company carried out a re-measurement of the valuation of the unvested warrants as at December 31, 2014, in accordance with ASC 505. The Company estimated that vesting of the unvested warrants will take place over the three years to December 31, 2017. The unvested warrants were re-measured at $583,829 using the Black-Scholes Option Pricing model using the following assumptions: Three-year term, $3.90 stock price, $2.47 exercise price, 233% volatility, 1.1% risk free rate. As of December 31, 2014, $439,175 of the $745,156 value of vested and unvested warrants has been expensed. On November 17, 2014, the Company issued 19,000 warrants to an agent, as part remuneration in respect of the issuance of 237,500 shares for net proceeds of $654,464. The warrants are immediately exercisable over a period of three years at $3.75 per share. The warrants were valued at $72,694 using the Black-Scholes Option Pricing model using the following assumptions: Three year term, $3.99 stock price, $3.75 exercise price, 234% volatility, 0.96% risk free rate. All of the 1,530,975 warrants issued on February 26, 2014, have been treated as a derivative liability, in accordance with ASC 815, owing to a ratchet provision in the warrant agreement being effective for the twelve months to February 26, 2015. The derivative liability was measured at $4,078,054 as at February 26, 2014. It was re-measured as of March 31, 2014, and revalued at $4,182,748. The derivative liability was further re-measured as of June 30, 2014, and revalued at $2,315,506, resulting in a gain of $1,867,241 for the three months ended June 30, 2014. At September 30, 2014, the derivative liability was re-measured and revalued at $6,446,068, resulting in a loss of $4,130,562 for the three months ended September 30, 2014. On October 31, 2014, the Company amended the terms of 1,121,225 of the aforementioned 1,530,975 warrants that had been issued on February 26, 2014. As a result of the amendment, the ratchet provision on the 1,121,225 warrants ceased on October 31, 2014. The derivative liability was re-measured at that date, using the Black-Scholes Option Pricing model with the following assumptions: Five year term, $3.54 stock price, $2.20 exercise price, 235% volatility, 1.62% risk free rate. This resulted in a gain of $1,086,727 for the month of October 2014 and the 1,121,225 warrants ceased to be a derivative liability with their valuation of $3,924,967 being transferred into Additional paid-in capital. On December 31, 2014 the remaining warrants treated as a derivative liability were re-measured. This resulted in a loss of $143,267 for the two months to December 31, 2014. The net gain for the three months to December 31, 2014 is therefore $943,460. Below is a table summarizing the warrants issued and outstanding as of December 31, 2015.
Date Issued |  | Number Outstanding |  |  | Exercise Price $ |  |  | Contractual Life (Years) |  |  | Expiration Date |  | Proceeds to Company if Exercised $ |
03/15/11 |  |  | 100,000 |  |  |  | 0.50 |  |  |  | 5 |  |  | 3/15/2016 |  |  | 50,000 |
03/24/11 |  |  | 100,000 |  |  |  | 0.50 |  |  |  | 5 |  |  | 3/24/2016 |  |  | 50,000 |
04/01/11 |  |  | 100,000 |  |  |  | 0.50 |  |  |  | 5 |  |  | 4/1/2016 |  |  | 50,000 |
06/21/11 |  |  | 100,000 |  |  |  | 0.50 |  |  |  | 5 |  |  | 6/21/2016 |  |  | 50,000 |
05/11/12 |  |  | 344,059 |  |  |  | 2.60 |  |  |  | 4 |  |  | 05/10/16 |  |  | 894,553 |
03/20/13 |  |  | 150,000 |  |  |  | 2.47 |  |  |  | 3 |  |  | 03/20/16 to 12/20/19 |  |  | 370,500 |
06/10/13 |  |  | 29,750 |  |  |  | 2.00 |  |  |  | 5 |  |  | 12/10/18 |  |  | 59,500 |
08/07/13 |  |  | 45,000 |  |  |  | 2.40 |  |  |  | 3 |  |  | 08/07/16 |  |  | 108,000 |
11/25/13 |  |  | 456,063 |  |  |  | 2.40 |  |  |  | 5 |  |  | 11/25/18 |  |  | 1,094,551 |
12/31/13 |  |  | 64,392 |  |  |  | 2.40 |  |  |  | 5 |  |  | 11/25/18 |  |  | 154,541 |
01/28/14 |  |  | 2,000 |  |  |  | 2.40 |  |  |  | 3 |  |  | 01/28/17 |  |  | 4,800 |
02/26/14 |  |  | 1,068,475 |  |  |  | 2.20 |  |  |  | 5 |  |  | 02/26/19 |  |  | 2,350,645 |
09/05/14 |  |  | 10,000 |  |  |  | 2.40 |  |  |  | 3 |  |  | 09/05/17 |  |  | 24,000 |
09/26/14 |  |  | 24,000 |  |  |  | 3.00 |  |  |  | 3 |  |  | 09/26/17 |  |  | 72,000 |
11/17/14 |  |  | 19,000 |  |  |  | 3.75 |  |  |  | 3 |  |  | 11/17/17 |  |  | 71,250 |
|  |  | 2,612,739 |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,404,340 |
b) Options On October 30, 2015, the Company adopted and approved the 2015 Stock Incentive Plan for the directors, officers, employees and consultants to the Company. Pursuant to the Plan, the Company is authorized to issue 1,000,000 shares of the Company's common stock. 2015 On May 18, 2015, the Company granted options to purchase 20,000 shares. These options vest six months after the date of grant, and expire four years after the vesting date, with an exercise price of $3.80 per share. The Company has calculated the estimated fair market value of these options using the Black-Scholes Option Pricing model and the following assumptions: term 4.5 years, stock price $3.45, exercise price $3.80, 72.1% volatility, 1.54% risk free rate. On May 18, 2015, the Company amended the expiry period of 630,000 stock options, originally granted on November 25, 2011. The expiration period was extended from three to four years for all 630,000 stock options. As a result, an additional $20,796 of stock option amortization was realized in 2015. On July 23, 2015, the Company granted options to purchase 327,000 shares, at an exercise price of $4.00 per share. All of the 327,000 options will vest on January 23, 2016 and will expire on January 23, 2020. The Company has calculated the estimated fair market value of these options using the Black-Scholes Option Pricing model and the following assumptions: term 4.5 years, stock price $3.55, exercise price $4.00, 88.3% volatility, 1.65% risk free rate. On August 14, 2015, the Company amended the vesting date of 10,000 stock options, originally granted on August 18, 2014, from August 18, 2015 to August 16, 2015. On August 17, 2015, the Company granted options to purchase 75,000 shares, at an exercise price of $3.75 per share. All of the 75,000 options vested on August 17, 2015 and will expire on August 17, 2020. The Company has calculated the estimated fair market value of these options using the Black-Scholes Option Pricing model and the following assumptions: term 5.0 years, stock price $3.31, exercise price $3.75, 87.9% volatility, 1.58% risk free rate. On November 18, 2015, stock options were exercised to purchase 20,000 shares of our common stock at $3.00 per share in cashless exercises that resulted in the issuance of 4,810 shares of common stock. On December 2, 2015, stock options were exercised to purchase 50,000 shares of our common stock at $3.01 per share in cashless exercises that resulted in the issuance of 14,081 shares of common stock to a related party. On December 9, 2015, stock options were exercised to purchase 50,000 shares of our common stock at $3.01 per share in cashless exercises that resulted in the issuance of 14,166 shares of common stock to a related party. During the year ended December 31, 2015, 40,000 options expired unexercised following the cessation of a consultant's contract. 2014 Options to purchase 25,000 shares were granted on May 16, 2014. These options vest in equal six monthly installments over three years from the date of grant, and expire three years after the vesting dates. The exercise prices are $3.00 for options vesting in the first year, $4.00 for options vesting in the second year, and $5.00 for options vesting in the third year. The Company has calculated the estimated fair market value of these options using the Black-Scholes Option Pricing model and the following assumptions: term 3 to 5.5 years, stock price $2.01, exercise prices $3.00-$5.00, 235% volatility, 0.80% risk free rate. On August 5, 2014, it was approved at the Company's Annual General Meeting to increase the number of restricted shares that the Company is authorized to issue under the 2011 Equity Incentive Plan to 2,000,000. On August 18, 2014, the Company granted options to purchase 670,000 shares. These options vest in two equal tranches, the first tranche vests on February 18, 2015. The second tranche vests on February 18, 2016. All the options expire four years after their vesting dates. The exercise prices are $2.50 for options vesting in the first year and $3.00 for options vesting in the second year. The Company has calculated the estimated fair market value of these options using the Black-Scholes Option Pricing model and the following assumptions: term 4.5 to 5.5 years, stock price $1.85, exercise prices $2.50-$3.00, 237% volatility, 1.58% risk free rate. On August 18, 2014, the Company granted options to purchase 60,000 shares. These options vest in equal six monthly installments over three years, starting six months after the date of grant, and expire three years after the vesting dates. The exercise prices are $3.00 for options vesting in the first year, $4.00 for options vesting in the second year, and $5.00 for options vesting in the third year. The Company has calculated the estimated fair market value of these options using the Black-Scholes Option Pricing model and the following assumptions: term 3.5 to 6 years, stock price $1.85, exercise prices $3.00-$5.00, 237% volatility, 0.89% risk free rate. During the year ended December 31, 2014, 60,000 options expired, following the cessation of a consultant's contract. Below is a table summarizing the options issued and outstanding as of December 31, 2015. Below is a table summarizing the options issued and outstanding as of December 31, 2015, which have a weighted average exercise price of $3.53 per share and a weighted average remaining contractual life of 3.0 years.
Date Issued |  | Number Outstanding |  |  | Exercise Price $ |  |  | Contractual Life (Years) |  |  | Expiration Date |  | Proceeds to Company if Exercised $ |
11/25/11 |  |  | 630,000 |  |  | 3.00-5.00 |  |  | 4.5-7.0 |  |  | 05/25/16-11/25/18 |  |  | 2,520,000 |
09/01/12 |  |  | 30,000 |  |  | 4.31-6.31 |  |  |  | 3.0 |  |  | 03/01/16-09/01/18 |  |  | 159,300 |
03/20/13 |  |  | 37,000 |  |  | 2.35-4.35 |  |  |  | 3.0 |  |  | 09/20/16-03/20/19 |  |  | 123,950 |
09/02/13 |  |  | 16,300 |  |  | 2.35-4.35 |  |  |  | 3.0 |  |  | 03/02/14-09/02/16 |  |  | 54,605 |
05/16/14 |  |  | 25,000 |  |  | 3.00-5.00 |  |  | 3.0-5.5 |  |  | 11/16/17-05/16/20 |  |  | 100,000 |
08/18/14 |  |  | 670,000 |  |  | 2.50-3.00 |  |  | 4.5-5.5 |  |  | 02/18/19-02/18/20 |  |  | 1,842,500 |
05/18/15 |  |  | 20,000 |  |  |  | 3.80 |  |  |  | 4.5 |  |  | 11/18/19 |  |  | 76,000 |
07/23/15 |  |  | 327,000 |  |  |  | 4.00 |  |  |  | 4.5 |  |  | 01/23/20 |  |  | 1,308,000 |
08/17/15 |  |  | 75,000 |  |  |  | 3.75 |  |  |  | 5.0 |  |  | 08/17/20 |  |  | 281,250 |
|  |  | 1,830,300 |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,465,605 |
Total remaining unrecognized compensation cost related to unvested stock options is approximately $159,096 and is expected to be recognized over a period of 1.5 years.

X
- References No definition available. + Details
Name: | VNRX_NotesToFinancialStatementsAbstract
Namespace Prefix: | VNRX_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants And Options {1} + References No definition available. + Details
Name: | VNRX_WarrantsAndOptionsTextBlock
Namespace Prefix: | VNRX_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration